Lei Yan, PhD
Associate Research Scientist in BiostatisticsCards
Contact Info
About
Titles
Associate Research Scientist in Biostatistics
Biography
I am an Associate Research Scientist in Biostatistics at Yale Public Health.
My research focuses on the application of advanced causal inference methods to questions in comparative effectiveness research, utilizing large electronic health records and other observational data to enhance health decision-making. Ongoing projects include estimating the causal effects of pharmacotherapies on the short- and long-term risk of COVID-19, examining the use of antidepressants and their effects on individuals with major depression, evaluating the effectiveness of respiratory syncytial virus vaccines, assessing the efficacy and duration of dolutegravir-based regimens for individuals with HIV, and investigating gene-environment interactions in the development of childhood acute lymphoblastic leukemia. These projects are conducted collaboratively with faculty and researchers at Yale Public Health and the Clinical Epidemiology Research Center (CERC) at the VA Connecticut Healthcare System located in West Haven. My previous research focused on the financialization of commodity markets.
Appointments
Biostatistics
Associate Research ScientistPrimary
Other Departments & Organizations
Education & Training
- Postdoctoral Research Associate
- University of Illinois at Urbana-Champaign (2018)
- PhD
- University of Illinois at Urbana-Champaign, Applied Economics (2017)
- MA
- Renmin University of China, Economics (2011)
- BS
- Renmin University of China, Statistics (2008)
Research
Overview
Public Health Interests
ORCID
0000-0002-4779-2688
Publications
Featured Publications
Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study
Bajema K, Yan L, Li Y, Argraves S, Rajeevan N, Fox A, Vergun R, Berry K, Bui D, Huang Y, Lin H, Hynes D, Lucero-Obusan C, Schirmer P, Cunningham F, Huang G, Aslan M, Ioannou G. Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study. The Lancet Infectious Diseases 2025 PMID: 39848264, DOI: 10.1016/s1473-3099(24)00796-5.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus vaccinePositive RSV testVaccine effectivenessRSV testCare encountersSecondary outcomesEmergency departmentRSV-associated hospitalisationsMedian follow-upUS Food and Drug AdministrationHealth-care useVeterans Health AdministrationRespiratory illness seasonMatched index dateElectronic health recordsLower respiratory tract diseaseRSV-related illnessFood and Drug AdministrationDepartment of Veterans Affairs Cooperative Studies ProgramVeterans Affairs Cooperative Studies ProgramCooperative Studies ProgramRSV infectionMedian ageUS DepartmentSeverity and Long-Term Mortality of COVID-19, Influenza, and Respiratory Syncytial Virus.
Bajema KL, Bui DP, Yan L, Li Y, Rajeevan N, Vergun R, Berry K, Huang Y, Lin HM, Aslan M, Ioannou GN. Severity and Long-Term Mortality of COVID-19, Influenza, and Respiratory Syncytial Virus. JAMA Intern Med 2025 PMID: 39869355, DOI: 10.1001/jamainternmed.2024.7452.Peer-Reviewed Original ResearchEffectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS)
Yan L, Henegar C, Marconi V, Gordon K, Hicks C, Vannappagari V, Justice A, Aslan M. Effectiveness of dolutegravir-based regimens compared to raltegravir-, elvitegravir-, bictegravir, and darunavir-based regimens among older adults with HIV in the Veterans Aging Cohort Study (VACS). AIDS Research And Therapy 2024, 21: 96. PMID: 39709467, PMCID: PMC11662819, DOI: 10.1186/s12981-024-00681-w.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsMeSH KeywordsAgedAmidesAnti-HIV AgentsCohort StudiesDarunavirDrug Therapy, CombinationFemaleHeterocyclic Compounds, 3-RingHeterocyclic Compounds, 4 or More RingsHIV InfectionsHIV Integrase InhibitorsHumansMaleMiddle AgedOxazinesPiperazinesPyridazinesPyridonesQuinolonesRaltegravir PotassiumTreatment OutcomeVeteransViral LoadConceptsVeterans Aging Cohort StudyRAL-based regimenAntiretroviral therapyAging Cohort StudyCohort studyOdds of virologic suppressionIntegrase strand transfer inhibitorsDarunavir-based regimensDolutegravir-based regimensDTG-based regimensAntiretroviral therapy experienceHuman immunodeficiency virusDTG-based regimenInverse probability of treatment weightingStrand transfer inhibitorsBackgroundReal-world dataProbability of treatment weightingMethodsThis cohort studyVirologic suppressionVirological failureVirological effectImmunodeficiency virusDarunavir/ritonavirClinical outcomesRegimen initiationIdentifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation
Yan L, Bui D, Li Y, Rajeevan N, Rowneki M, Berry K, Argraves S, Huang Y, Hynes D, Cunningham F, Huang G, Aslan M, Ioannou G, Bajema K. Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation. Clinical Infectious Diseases 2024, 79: 643-651. PMID: 38864601, DOI: 10.1093/cid/ciae202.Peer-Reviewed Original ResearchConceptsRisk quartileVeterans Health AdministrationLowest risk quartileHighest risk quartileTarget trial emulationRisk prediction modelUntreated veteransRisk of deathOlder veteransYounger veteransHealth AdministrationTrial emulationMeasure incidenceNirmatrelvir-ritonavirVeteransHospitalUntreated participantsCOVID-19QuartileRiskSevere coronavirus disease 2019ParticipantsPersonsCoronavirus disease 2019Severe COVID-19
2025
Deconstructing fertilizer price spikes: Evidence from Chinese urea fertilizer market
Hu Z, Yan L, Yuan J, Etienne X (2025). Deconstructing fertilizer price spikes: Evidence from Chinese urea fertilizer market. Food Policy, 133.Peer-Reviewed Original ResearchEffectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation.
Ioannou GN, Berry K, Rajeevan N, Li Y, Yan L, Huang Y, Lin HM, Bui D, Hynes DM, Rowneki M, Bohnert A, Boyko EJ, Iwashyna TJ, Maciejewski ML, Smith VA, Berkowitz TSZ, O'Hare AM, Viglianti EM, Aslan M, Bajema KL. Effectiveness of the 2023-to-2024 XBB.1.5 COVID-19 Vaccines Over Long-Term Follow-up : A Target Trial Emulation. Ann Intern Med 2025 PMID: 39903865, DOI: 10.7326/ANNALS-24-01015.Peer-Reviewed Original Research
2024
Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients–March 2022—April 2023
Bui D, Bajema K, Huang Y, Yan L, Li Y, Rajeevan N, Berry K, Rowneki M, Argraves S, Hynes D, Huang G, Aslan M, Ioannou G. Development of a prediction model for 30-day COVID-19 hospitalization and death in a national cohort of Veterans Health Administration patients–March 2022—April 2023. PLOS ONE 2024, 19: e0307235. PMID: 39365775, PMCID: PMC11451987, DOI: 10.1371/journal.pone.0307235.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsVeterans Health AdministrationCOVID-19 hospitalizationArea under the receiver operating characteristic curveComprehensive electronic health recordNational cohortElectronic health recordsAll-cause mortalityNational cohort of patientsFull modelHealth recordsHealth AdministrationReceipt of COVID-19 vaccineMortality riskEpidemiology of COVID-19COVID-19High-risk patientsBrier scoreCohort of patientsAnti-SARS-CoV-2 treatmentCOVID-19 vaccineReceiver operating characteristic curveCalibration interceptHospitalAntiviral treatmentAvailability of effective vaccinesRegional variation in financial hardship among US veterans during the COVID-19 pandemic
Hauschildt K, Bui D, Govier D, Eaton T, Viglianti E, Ettman C, McCready H, Smith V, O’Hare A, Osborne T, Boyko E, Ioannou G, Maciejewski M, Bohnert A, Hynes D, Iwashyna T, Chai W, Bowling B, Maciejewski M, Womer J, Iwashyna T, Anderson S, Bernstein T, Cabrales A, Hauschildt K, Admon A, Byrd K, Cano J, Curtis J, DelMonico E, Horowitz D, Kamphius L, Korpela P, Kumbier K, Langa K, Prescott H, Rouse M, Saini S, Seelye S, Sussman J, Wawrin N, Monahan M, Bohnert A, Viglianti E, Akgun K, Aslan M, Cheung K, Li Y, Mutalik P, Rajeevan N, Yan L, Anderson L, Berkowitz T, Bogdan J, Bosworth H, Boucher N, Cummin G, Dennis P, Floyd B, Hastings S, Kaufman B, Meyer C, Miles A, Naylor J, Shepherd-Banigan M, Smith V, Smith B, Woods C, Dobalian A, Goetz M, Ikuta K, Ong M, Shaukat A, Backus L, Ferguson J, Osborne T, Shahoumian T, Veigulis Z, Zulman D, Bajema K, Bui D, Chen J, Govier D, Helfand M, Hickok A, Hough C, McCready H, Moss A, Newell S, Niederhausen M, Nugent S, Saha S, Slatore C, Takata Y, Teo A, Tuepker A, Vranas K, Winchell K, Hynes D, Boyko E, Au D, Baraff A, Berry Wyatt K, Borgerding J, Burwick N, Crothers K, Davis M, Doll J, Dominitz J, Eastment M, Fan V, Fox A, Hawkins E, Hebert P, Hu E, Korpak A, Morelli D, Peterson A, Reddy A, Shah J, Showalter W, Smith N, Suri P, Thomas E, Turner A, Vig E, Wicks K, Wong E, Wysham K, Ioannou G, O'Hare A, Jones B, Jones M, Knight S. Regional variation in financial hardship among US veterans during the COVID-19 pandemic. Health Affairs Scholar 2024, 2: qxae075. PMID: 38938272, PMCID: PMC11210296, DOI: 10.1093/haschl/qxae075.Peer-Reviewed Original ResearchSelf-Reported Everyday Functioning After COVID-19 Infection
Iwashyna T, Smith V, Seelye S, Bohnert A, Boyko E, Hynes D, Ioannou G, Maciejewski M, O’Hare A, Viglianti E, Berkowitz T, Pura J, Womer J, Kamphuis L, Monahan M, Bowling C, Admon A, Akgun K, Anderson S, Aslan M, Au D, Backus L, Bajema K, Baraff A, Batten L, Berkowitz T, Bernstein T, Berry Wyatt K, Bogdan J, Bosworth H, Boucher N, Burwick N, Cabrales A, Cano J, Chai W, Chen J, Cheung K, Crothers K, Curtis J, Davis M, Del Monico E, Dobalian A, Doll J, Dominitz J, Eastment M, Fan V, Ferguson J, Floyd B, Fox A, Goetz M, Govier D, Green P, Hastings S, Hauschildt K, Hawkins E, Hebert P, Helfand M, Hickok A, Horowitz D, Hough C, Hu E, Ikuta K, Jones B, Jones M, Kamphuis L, Kaufman B, Knight S, Korpak A, Korpela P, Kumbier K, Langa K, Laundry R, Lavin S, Li Y, Linquist J, McCready H, Michel M, Miles A, Milne J, Monahan M, Morelli D, Mutalik P, Naylor J, Neiderhausen M, Newell S, Nugent S, Ong M, Osborne T, Peterson M, Peterson A, Prescott H, Rajeevan N, Reddy A, Rouse M, Rowneki M, Saha S, Saini S, Shah J, Shahoumian T, Shaukat A, Shepherd-Banigan M, Showalter W, Slatore C, Smith N, Smith B, Suri P, Sussman J, Takata Y, Teo A, Thomas E, Thomas L, Tuepker A, Veigulis Z, Vig E, Vranas K, Wang X, Wicks K, Winchell K, Wong E, Woods C, Wysham K, Yan L, Zulman D. Self-Reported Everyday Functioning After COVID-19 Infection. JAMA Network Open 2024, 7: e240869. PMID: 38427352, PMCID: PMC10907923, DOI: 10.1001/jamanetworkopen.2024.0869.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsEveryday functioningActivities of daily livingSelf-reported everyday functioningCOVID-19 infectionImpact of COVID-19 infectionDaily livingVeterans AffairsCOVID-19 cohortDocumented COVID-19Instrumental activities of daily livingMatched pairs of participantsHealth-related quality of lifePairs of participantsCohort studyProportion of veteransControl cohortLife-space mobilityStudy of veteransCohort study of veteransUS Veterans AffairsHealth-related qualityDocumented COVID-19 infectionSelf-reportTarget trial emulationQuality of lifeChanges in Outpatient Health Care Use After COVID-19 Infection Among Veterans
Hebert P, Kumbier K, Smith V, Hynes D, Govier D, Wong E, Kaufman B, Shepherd-Banigan M, Rowneki M, Bohnert A, Ioannou G, Boyko E, Iwashyna T, O’Hare A, Bowling C, Viglianti E, Maciejewski M, Admon A, Akgun K, Anderson L, Anderson S, Aslan M, Au D, Backus L, Bajema K, Baraff A, Batten L, Berkowitz T, Bernstein T, Berry Wyatt K, Bogdan J, Borgerding J, Bosworth H, Boucher N, Burwick N, Byrd K, Cabrales A, Cano J, Chai W, Chen J, Cheung K, Crothers K, Cummin G, Curtis J, Davis M, Del Monico E, Dennis P, Dobalian A, Doll J, Dominitz J, Eastment M, Fan V, Ferguson J, Floyd B, Fox A, Goetz M, Green P, Hastings S, Hauschildt K, Hawkins E, Helfand M, Hickok A, Horowitz D, Hough C, Hu E, Ikuta K, Jones B, Jones M, Kamphius L, Knight S, Korpak A, Korpela P, Langa K, Laundry R, Lavin S, Li Y, Lindquist J, McCready H, Meyer C, Michel M, Miles A, Milne J, Monahan M, Morelli D, Mutalik P, Naylor J, Niederhausen M, Newell S, Nugent S, Ong M, Osborne T, Peterson M, Peterson A, Prescott H, Pura J, Rajeevan N, Reddy A, Rouse M, Saha S, Saini S, Seelye S, Shah J, Shahoumian T, Shaukat A, Showalter W, Slatore C, Smith B, Smith N, Streja E, Suri P, Sussman J, Takata Y, Teo A, Thomas E, Thomas L, Tuepker A, Turner A, Veigulis Z, Vig E, Vranas K, Wang X, Wicks K, Winchell K, Womer J, Woods C, Wysham K, Yan L, Zulman D. Changes in Outpatient Health Care Use After COVID-19 Infection Among Veterans. JAMA Network Open 2024, 7: e2355387. PMID: 38334995, PMCID: PMC10858406, DOI: 10.1001/jamanetworkopen.2023.55387.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsOutpatient health care useHealth care useCare useOutpatient useOutpatient visitsPrimary care visitsCounts of outpatient visitsPrimary care patientsOutpatient care utilizationCategories of careVeterans Affairs Corporate Data WarehouseCorporate Data WarehouseIncreased outpatient visitsNegative binomial regression modelsBinomial regression modelsCare visitsCare utilizationPopulation surveillance studyRetrospective cohort studyCare patientsUninfected veteransCOVID-19 infectionMain OutcomesPeri-infection periodCohort study
Get In Touch
Contacts
Locations
300 George Street
Academic Office
Rm 509
New Haven, CT 06511